These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 20298399)

  • 21. Fluticasone propionate/salmeterol and exercise-induced asthma in children with persistent asthma.
    Pearlman D; Qaqundah P; Matz J; Yancey SW; Stempel DA; Ortega HG
    Pediatr Pulmonol; 2009 May; 44(5):429-35. PubMed ID: 19382218
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Asthma control with the salmeterol-fluticasone-combination disc compared to standard treatment].
    Molitor S; Liefring E; Trautmann M
    Pneumologie; 2005 Mar; 59(3):167-73. PubMed ID: 15756629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Salmeterol/fluticasone propionate vs. double dose fluticasone propionate on lung function and asthma control in children.
    de Blic J; Ogorodova L; Klink R; Sidorenko I; Valiulis A; Hofman J; Bennedbaek O; Anderton S; Attali V; Desfougeres JL; Poterre M
    Pediatr Allergy Immunol; 2009 Dec; 20(8):763-71. PubMed ID: 19239660
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Superiority of "triple" therapy with salmeterol/fluticasone propionate and tiotropium bromide versus individual components in moderate to severe COPD.
    Singh D; Brooks J; Hagan G; Cahn A; O'Connor BJ
    Thorax; 2008 Jul; 63(7):592-8. PubMed ID: 18245142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adding salmeterol to an inhaled corticosteroid: long term effects on bronchial inflammation in asthma.
    Koopmans JG; Lutter R; Jansen HM; van der Zee JS
    Thorax; 2006 Apr; 61(4):306-12. PubMed ID: 16449264
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Early onset of effect of salmeterol and fluticasone propionate in chronic obstructive pulmonary disease.
    Vestbo J; Pauwels R; Anderson JA; Jones P; Calverley P;
    Thorax; 2005 Apr; 60(4):301-4. PubMed ID: 15790985
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adherence to asthma controller medication regimens.
    Stempel DA; Stoloff SW; Carranza Rosenzweig JR; Stanford RH; Ryskina KL; Legorreta AP
    Respir Med; 2005 Oct; 99(10):1263-7. PubMed ID: 16140227
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of salmeterol/fluticasone propionate combination on airway hyper-responsiveness in patients with well-controlled asthma.
    Chanez P; Stallaert R; Reznikova E; Bloemen P; Adamek L; Joos G
    Respir Med; 2010 Aug; 104(8):1101-9. PubMed ID: 20452196
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement in asthma endpoints when aiming for total control: salmeterol/fluticasone propionate versus fluticasone propionate alone.
    Woodcock AA; Bagdonas A; Boonsawat W; Gibbs MR; Bousquet J; Bateman ED;
    Prim Care Respir J; 2007 Jun; 16(3):155-61. PubMed ID: 17551661
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Components of asthma control and treatment response of individual control criteria in children: analysis of the PEACE study.
    Pedersen S; Maspero J; Gul N; Sharma R
    Pediatr Pulmonol; 2011 Dec; 46(12):1182-8. PubMed ID: 21751432
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of fluticasone propionate-salmeterol therapy on seasonal changes in airway responsiveness and exhaled nitric oxide levels in patients with pollen-induced asthma.
    Prieto L; Gutiérrez V; Pérez-Francés C; Badiola C; Lanuza A; Bruno L; Ferrer A
    Ann Allergy Asthma Immunol; 2005 Nov; 95(5):452-61. PubMed ID: 16312168
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of combination of fluticasone propionate and salmeterol xinafoate on lung function improvement in patients with bronchiectasis.
    Mostafapour E; Mousavi SA; Shahmiri SS; Fereshtehnejad SM
    Lijec Vjesn; 2009 Nov; 131 Suppl 6():8-11. PubMed ID: 22046624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Observation on the effects of the treatment of sillicosis merger asthma].
    Wu XH; Cai C; Xu JP; Ru CH; He F
    Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2013 May; 31(5):386-8. PubMed ID: 24079038
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transient sputum eosinophilia may occur over time in non-eosinophilic asthma and this is not prevented by salmeterol.
    Bacci E; Latorre M; Cianchetti S; Bartoli M; Costa F; Di Franco A; Malagrinò L; Novelli F; Vagaggini B; Dente FL; Paggiaro P
    Respirology; 2012 Nov; 17(8):1199-206. PubMed ID: 22882543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poor disease control among insured users of high-dose combination therapy for asthma.
    Broder MS; Chang EY; Kamath T; Sapra S
    Allergy Asthma Proc; 2010; 31(1):60-7. PubMed ID: 20167146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cost-effectiveness of asthma control: an economic appraisal of the GOAL study.
    Briggs AH; Bousquet J; Wallace MV; Busse WW; Clark TJ; Pedersen SE; Bateman ED;
    Allergy; 2006 May; 61(5):531-6. PubMed ID: 16629780
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Compliance with maintenance treatment of asthma (ADERE study).
    Chatkin JM; Cavalet-Blanco D; Scaglia NC; Tonietto RG; Wagner MB; Fritscher CC
    J Bras Pneumol; 2006; 32(4):277-83. PubMed ID: 17268725
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Achieving guideline-based asthma control: does the patient benefit?
    Bateman ED; Frith LF; Braunstein GL
    Eur Respir J; 2002 Sep; 20(3):588-95. PubMed ID: 12358333
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pharmacists helping physicians.
    Bowes D
    CMAJ; 2003 Jan; 168(2):151. PubMed ID: 12538538
    [No Abstract]   [Full Text] [Related]  

  • 40. [Dynamics of functional parameters in different schemes for bronchial asthma therapy: results of the STRELA-ACT multicentre study].
    Ogorodova LM; Kulikov ES; Deev IA; Cherniak BA; Fassakhov RS
    Klin Med (Mosk); 2011; 89(4):36-41. PubMed ID: 21932561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.